Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma

Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma

IntroductionDiffuse large B-cell lymphoma (DLBCL) is the most common subtypes of lymphoma. Clinical biomarkers are still required for DLBCL patients to identify high-risk patients. Therefore, we developed and validated the platelet-to-albumin (PTA) ratio as a predictor for DLBCL patients.MethodsA gr...

Full description

Bibliographic Details
Main Authors: Jinghan Wang, Linjie Li, Fang Yu, Junyu Zhang, Liping Mao, Bocheng Chen, Xuelian Hu, Hongmei Zhou, Wanzhuo Xie, Hongyan Tong, Jie Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
diffuse large B-cell lymphoma
U-shaped relationship
survival
clinical parameters
platelet counts
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1138284/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1138284/full

Similar Items